These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6396097)

  • 21. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mineralocorticoids on the paradoxical glucose-induced hyperkalemia in nondiabetic patients with selective hypoaldosteronism.
    Rado JP
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):365-8. PubMed ID: 918352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group.
    Mirkin BL; Newman TJ
    Pediatrics; 1985 Jun; 75(6):1091-100. PubMed ID: 3889818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
    Overlack A; Stumpe KO; Heck I; Krück F
    Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of minoxidil and captopril in the treatment of refractory hypertension.
    Matson JR; Norby LH; Robillard JE
    Am J Dis Child; 1981 Mar; 135(3):256-8. PubMed ID: 7010994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperkalemia resulting from captopril administration.
    Warren SE; O'Connor DT
    JAMA; 1980 Dec; 244(22):2551-2. PubMed ID: 7001073
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes of the intralymphocytic sodium concentration after acute and chronic captopril administration.
    Santucci A; Aguglia F; Violi F; De Mattia G
    Am J Cardiol; 1982 Apr; 49(6):1513-4. PubMed ID: 7041589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between glucose-induced elevation of serum potassium in the upright posture, hormonal changes and renal functions in captopril-treated hypertensives.
    Radó JP; Gercsák G; Bános C
    Horm Metab Res; 1984 Jan; 16(1):57. PubMed ID: 6365717
    [No Abstract]   [Full Text] [Related]  

  • 29. Captopril: reversible renal failure with severe hyperkalaemia.
    Grossman A; Eckland D; Price P; Edwards CR
    Lancet; 1980 Mar; 1(8170):712. PubMed ID: 6103125
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of amiloride on oral glucose loading, serum potassium, renin, and aldosterone in diet-controlled diabetes.
    Lowenthal DT; Gould A; Shirk J; Mazzella J; Affrime MB; Walker F; Onesti G
    Clin Pharmacol Ther; 1980 May; 27(5):671-6. PubMed ID: 6989547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose-induced paradoxical increase in HGH with potentiated decrease in serum potassium in chronic renal failure.
    Rado JP
    Horm Metab Res; 1982 Feb; 14(2):105. PubMed ID: 7040190
    [No Abstract]   [Full Text] [Related]  

  • 32. Captopril and increased serum potassium levels.
    Burnakis TG
    JAMA; 1984 Oct; 252(13):1682-3. PubMed ID: 6381779
    [No Abstract]   [Full Text] [Related]  

  • 33. Captopril-induced metabolic acidosis with hyperkalemia.
    Sakemi T; Ohchi N; Sanai T; Rikitake O; Maeda T
    Am J Nephrol; 1988; 8(3):245-8. PubMed ID: 3071139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous changes of serum potassium levels in NIDDM patients on oral glucose load.
    Bae HY; Kim HJ
    Korean J Intern Med; 1992 Jan; 7(1):39-47. PubMed ID: 1477029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucose tolerance during chronic captopril therapy in patients with essential hypertension.
    Shionoiri H; Miyakawa T; Takasaki I; Ishikawa Y; Hiroto S; Kaneko Y; Shindo Y
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):160-4. PubMed ID: 2435993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Life-threatening hyperkalemia associated with captopril administration.
    Doman K; Perlmutter JA; Muhammedi M; Puschett JB
    South Med J; 1993 Nov; 86(11):1269-72. PubMed ID: 8235783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of pharmacological doses of aldosterone on the hyperosmolality-induced hyperkalemia.
    Rado JP
    Horm Metab Res; 1977 May; 9(3):251. PubMed ID: 195884
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatitis associated with captopril treatment.
    Vandenburg M; Parfrey P; Wright P; Lazda E
    Br J Clin Pharmacol; 1981 Jan; 11(1):105-6. PubMed ID: 7011347
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of prolonged nifedipine or captopril therapy on lymphocyte magnesium and potassium levels in hypertension.
    Lavin F; O'Keeffe S; Grimes H; Finn J; Mannion A; Daly K
    Cardiology; 1993; 82(6):405-8. PubMed ID: 8402763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful reintroduction of captopril following neutropenia.
    Edwards CR; Drury P; Penketh A; Damluji SA
    Lancet; 1981 Mar; 1(8222):723. PubMed ID: 6110936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.